Once Upon a Farm, PBC (OFRM), the Berkeley, California-based maker of organic snacks and meals for babies and kids, saw its shares tumble in Monday's session as investors reacted to a sweeping product recall. The stock, which closed the prior session at $15.02, was trading near $10.68 in midday action, a decline of roughly 28.9%. The drop accelerated after the company confirmed a nationwide recall and reformulation of its Tractor Wheels soft-baked toddler bars, a move that followed an FDA advisory flagging a potentially fatal choking hazard.
The sell-off centers on the company's decision to pull all flavors, package sizes, and lots of its Tractor Wheels soft-baked bars from the market. The action came after the U.S. Food and Drug Administration issued an urgent advisory warning that the toddler snack line — marketed to children roughly 1.5 to 2.5 years old — could form a dense, sticky mass when chewed, creating an airway obstruction that standard first-aid measures have struggled to clear.
Three consumer complaints preceded the recall, and management acknowledged that it had fallen short of customer trust while pledging to act swiftly alongside federal authorities. The company also said it would reformulate the affected line. The three recalled varieties were distributed nationwide through e-commerce platforms and major retailers including Target, Walmart, and Costco, widening the operational and financial exposure.
For a brand built on organic ingredients, transparency, and parental trust, a safety-related recall in the toddler category carries outsized weight. Beyond immediate costs — inventory write-offs, refunds, and logistics — analysts are weighing the longer-term threat to retail shelf space and the premium pricing the brand commands. A recall that touches on child safety strikes at the core of the company's value proposition, and the market appeared to be pricing in both near-term disruption and potential damage to consumer confidence.
The company has not yet quantified the financial impact of the recall, and the absence of specifics added to the uncertainty. Management hosted a business update conference call Monday morning, led by co-founder and CEO John Foraker, to address the recall's scope and the reformulation timeline.
Trading volume was elevated as investors repositioned following the recall disclosure, and the stock moved toward multi-month lows. The decline stood in contrast to a firmer broader market, underscoring that the weakness was company-specific rather than a reflection of sector or macro pressure. A notable short interest — reported near 13.4% of the float, or roughly 17 days to cover — likely magnified the downside as the negative news triggered accelerated selling and potential short-squeeze dynamics in reverse.
The move also pushed the shares well below their $18 IPO reference price from February, adding to the technical damage and testing levels not seen since shortly after the company's public debut.
The immediate focus for OFRM is management's commentary on the recall's scope, the timeline for reformulation, and any expected impact on results. Investors will also monitor for further FDA communication or additional consumer complaints that could widen the recall.
Third-quarter fiscal 2026 earnings are scheduled for November 12, when the company will face questions about recall-related costs and whether the disruption affects demand across the rest of its portfolio. Risks include potential reputational spillover into other product lines, retailer reassessment of shelf allocations, and elevated near-term expenses. On the other side, a contained recall with a swift reformulation and no broader demand impact could support stabilization once the immediate shock passes.
Tickeron's Trending AI Robots page curates a selection of AI-powered trading bots that span hundreds of strategies and thousands of tickers, highlighting only those performing strongest under current market conditions. The featured bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a filtered view of what is working in real time. Explore the page to see which automated approaches are gaining traction right now.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
OFRM's Aroon Indicator triggered a bullish signal on October 29, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 10 similar instances where the Aroon Indicator showed a similar pattern. In 8 of the 10 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 80%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where OFRM advanced for three days, in 32 of 41 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
OFRM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OFRM as a result. In 7 of 9 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for OFRM turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 4 similar instances when the indicator turned negative. In 3 of the 4 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
OFRM moved below its 50-day moving average on October 21, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OFRM crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 1 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.062) is normal, around the industry mean (7.678). OFRM's P/E Ratio (-66.330) is considerably lower than the industry average of (6.461). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (2.382) is also within normal values, averaging (5.003).
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 68 (best 1 - 100 worst), indicating slightly worse than average price growth. OFRM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry FoodMajorDiversified